Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|December 16, 2000
Lobaplatin: a new antitumour platinum drugM J McKeageJournal of Inorganic Biochemistry|January 8, 2000
Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approachesD Screnci, M J McKeageDrugs & Aging|August 1, 1994
New platinum agents. A comparison in ovarian cancerL R Kelland, M J McKeageThe New Zealand Medical Journal|October 25, 1989
Saliva lithium: a poor predictor of plasma and erythrocyte levelsM J McKeage, T J MalingJournal of Chromatography|March 8, 1991
Determination of xanthenone-4-acetic acid in mouse plasma by high-performance liquid chromatographyP Kestell, M J McKeage, B C BaguleyBritish Journal of Cancer|October 1, 1991
Platinum and other metal coordination compounds in cancer chemotherapy. A commentary on the sixth international symposium: San Diego, California, 23-26th January 1991M J McKeage, J D Higgins, L R KellandAustralian and New Zealand Journal of Medicine|April 1, 1990
Streptococcus zooepidemicus cellulitis and bacteraemia in a renal transplant recipientM J McKeage, M W Humble, R B MorrisonCancer Research|February 1, 1994
Lack of neurotoxicity of oral bisacetatoamminedichlorocyclohexylamine-platinum(IV) in comparison to cisplatin and tetraplatin in the ratM J McKeage, F E Boxall, M Jones, et al.Cancer Chemotherapy and Pharmacology|May 12, 2005
Oxaliplatin causes selective atrophy of a subpopulation of dorsal root ganglion neurons without inducing cell lossS M F Jamieson, J Liu, B Connor, et al.Pageof 4